These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6313148)
21. Supersensitivity of brain opiate receptor subtypes after chronic naltrexone treatment. Tempel A; Zukin RS; Gardner EL Life Sci; 1982 Sep 20-27; 31(12-13):1401-4. PubMed ID: 6292636 [No Abstract] [Full Text] [Related]
22. A study of central opioid receptor involvement in nitrous oxide analgesia in mice. Chen DC; Quock RM Anesth Prog; 1990 Jul; 37(4):181-5. PubMed ID: 1965769 [TBL] [Abstract][Full Text] [Related]
23. A rationale for opiate withdrawal symptomatology. Gold MS; Kleber HD Drug Alcohol Depend; 1979 Sep; 4(5):419-24. PubMed ID: 228923 [TBL] [Abstract][Full Text] [Related]
25. Pharmacology of psychotropic analgesic nitrous oxide as a multipotent opioid agonist. Gillman MA; Lichtigfeld FJ Int J Neurosci; 1994 May; 76(1-2):5-12. PubMed ID: 7960469 [TBL] [Abstract][Full Text] [Related]
26. [The state of opiate withdrawal]. Ruiz J; Saviuc P; Serve F; Cornier P Soins; 1991 Feb; (545):39-40. PubMed ID: 1850873 [No Abstract] [Full Text] [Related]
27. The uses of analgesic nitrous oxide in neuropsychiatry. Gillman MA; Lichtigfeld FJ S Afr Med J; 1994 Oct; 84(10):706. PubMed ID: 7839271 [No Abstract] [Full Text] [Related]
28. Clonidine for opiate withdrawal in the chronic pain patient. Bakris GL Postgrad Med; 1982 Mar; 71(3):240-1. PubMed ID: 6276875 [No Abstract] [Full Text] [Related]
29. The effect of morphine tolerance-dependence and abstinence on mu, delta, and kappa opiate receptors of discrete brain regions and spinal cord of the rat. Bhargava HN; Gulati A NIDA Res Monogr; 1990; 105():530-1. PubMed ID: 1652091 [No Abstract] [Full Text] [Related]
30. Cellular site of opiate dependence. Collier HO Nature; 1980 Feb; 283(5748):625-9. PubMed ID: 6243745 [TBL] [Abstract][Full Text] [Related]
31. Nitrous oxide-antinociception is mediated by opioid receptors and nitric oxide in the periaqueductal gray region of the midbrain. Emmanouil DE; Dickens AS; Heckert RW; Ohgami Y; Chung E; Han S; Quock RM Eur Neuropsychopharmacol; 2008 Mar; 18(3):194-9. PubMed ID: 17683915 [TBL] [Abstract][Full Text] [Related]
35. Opiate receptor involvement in the quasi-morphine withdrawal syndrome induced by acute injection of R 18 503. Ashton D; Wauquier A Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):148-50. PubMed ID: 6284078 [No Abstract] [Full Text] [Related]
36. Morphine-naloxone interactions: a role for nonspecific morphine excitatory effects in withdrawal. Stevens DR; Klemm WR Science; 1979 Sep; 205(4413):1379-8. PubMed ID: 224462 [TBL] [Abstract][Full Text] [Related]
37. Audiogenic seizures during ethanol withdrawal can be blocked by a delta opioid agonist. Kotlińska J; Langwiński R Drug Alcohol Depend; 1986 Dec; 18(4):361-7. PubMed ID: 3028746 [TBL] [Abstract][Full Text] [Related]
38. Modulation of brain alpha 2-adrenoceptor and mu-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats. Ulibarri I; García-Sevilla JA; Ugedo L Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):530-7. PubMed ID: 2830545 [TBL] [Abstract][Full Text] [Related]
39. Do nitrous oxide and halothane influence opioid receptor binding in SH-SY5Y human neuroblastoma cells? Campbell DJ; Rowbotham DJ; Lambert DG Br J Anaesth; 1995 Dec; 75(6):752-5. PubMed ID: 8672325 [TBL] [Abstract][Full Text] [Related]
40. Opioid dependence and cross-dependence in the isolated guinea-pig ileum. Schulz R; Seidl E; Wüster M; Herz A Eur J Pharmacol; 1982 Oct; 84(1-2):33-40. PubMed ID: 6291952 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]